Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001468203-09-000001
Filing Date
2009-07-13
Accepted
2009-07-10 18:12:01
Documents
1
Effectiveness Date
2009-07-13
Items
Item 06: Rule 506
Item 3C: Investment Company Act Section 3(c)
Item 3C.7: Section 3(c)(7)

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 6865
  Complete submission text file 0001468203-09-000001.txt   8435
Mailing Address 110 EAST 59TH STREET 33RD FLOOR NEW YORK NY 10022
Business Address 110 EAST 59TH STREET 33RD FLOOR NEW YORK NY 10022 212-883-2296
BioPharma Cayman Partners, LP (Filer) CIK: 0001468203 (see all company filings)

EIN.: 421768291 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-132649 | Film No.: 09940892